Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients

Clinical trial NCT07749014 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07749014
Sponsor: Rehman Medical Institute - RMI
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ST-elevation Myocardial Infarction (STEMI)Acute Myocardial Infarction (AMI)Coronary Artery Disease

Start date: 2026-09-01
Primary completion: 2027-09-30
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.